Veradigm (MDRX) Competitors $4.40 0.00 (0.00%) As of 03:46 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesOwnershipSEC FilingsSustainabilityTrendsBuy This Stock MDRX vs. OMCL, HSTM, CRTX, NTCT, VRNT, RBBN, SLP, OSPN, ECX, and UISShould you be buying Veradigm stock or one of its competitors? The main competitors of Veradigm include Omnicell (OMCL), HealthStream (HSTM), Cortexyme (CRTX), NetScout Systems (NTCT), Verint Systems (VRNT), Ribbon Communications (RBBN), Simulations Plus (SLP), OneSpan (OSPN), ECARX (ECX), and Unisys (UIS). Veradigm vs. Omnicell HealthStream Cortexyme NetScout Systems Verint Systems Ribbon Communications Simulations Plus OneSpan ECARX Unisys Veradigm (NASDAQ:MDRX) and Omnicell (NASDAQ:OMCL) are both small-cap business services companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, media sentiment, profitability, valuation, institutional ownership, dividends, community ranking, risk and analyst recommendations. Does the media favor MDRX or OMCL? In the previous week, Omnicell had 15 more articles in the media than Veradigm. MarketBeat recorded 17 mentions for Omnicell and 2 mentions for Veradigm. Omnicell's average media sentiment score of 0.94 beat Veradigm's score of 0.00 indicating that Omnicell is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Veradigm 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Omnicell 6 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has higher earnings and valuation, MDRX or OMCL? Omnicell has lower revenue, but higher earnings than Veradigm. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVeradigm$1.53B0.31N/AN/AN/AOmnicell$1.14B1.16$12.53M$0.4661.37 Do analysts rate MDRX or OMCL? Veradigm presently has a consensus target price of $14.00, suggesting a potential upside of 218.18%. Omnicell has a consensus target price of $44.83, suggesting a potential upside of 58.81%. Given Veradigm's higher probable upside, equities research analysts plainly believe Veradigm is more favorable than Omnicell.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Veradigm 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Omnicell 0 Sell rating(s) 3 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50 Is MDRX or OMCL more profitable? Omnicell has a net margin of 1.13% compared to Veradigm's net margin of 0.00%. Omnicell's return on equity of 3.82% beat Veradigm's return on equity.Company Net Margins Return on Equity Return on Assets VeradigmN/A N/A N/A Omnicell 1.13%3.82%2.07% Do insiders & institutionals have more ownership in MDRX or OMCL? 97.7% of Omnicell shares are held by institutional investors. 2.3% of Veradigm shares are held by insiders. Comparatively, 2.5% of Omnicell shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Which has more risk & volatility, MDRX or OMCL? Veradigm has a beta of 0.76, suggesting that its stock price is 24% less volatile than the S&P 500. Comparatively, Omnicell has a beta of 0.78, suggesting that its stock price is 22% less volatile than the S&P 500. Does the MarketBeat Community believe in MDRX or OMCL? Veradigm received 122 more outperform votes than Omnicell when rated by MarketBeat users. However, 66.71% of users gave Omnicell an outperform vote while only 57.55% of users gave Veradigm an outperform vote. CompanyUnderperformOutperformVeradigmOutperform Votes62957.55% Underperform Votes46442.45% OmnicellOutperform Votes50766.71% Underperform Votes25333.29% SummaryOmnicell beats Veradigm on 11 of the 14 factors compared between the two stocks. Get Veradigm News Delivered to You Automatically Sign up to receive the latest news and ratings for MDRX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MDRX vs. The Competition Export to ExcelMetricVeradigmComputer integrated systems design IndustryBusiness SectorNASDAQ ExchangeMarket Cap$476.37M$3.76B$24.21B$8.31BDividend YieldN/A2.13%2.62%4.10%P/E RatioN/A65.1832.5319.60Price / Sales0.3134.34252.54117.96Price / CashN/A34.8530.9334.62Price / BookN/A5.355.384.50Net IncomeN/A$37.12M$195.96M$248.40M7 Day Performance4.76%-1.29%-1.14%-1.00%1 Month Performance6.02%13.86%15.11%10.72%1 Year Performance-43.37%3.98%18.86%9.00% Veradigm Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MDRXVeradigm2.2644 of 5 stars$4.40flat$14.00+218.2%-42.1%$476.37M$1.53B0.008,000Analyst ForecastGap DownOMCLOmnicell2.4278 of 5 stars$27.85-0.4%$46.50+67.0%-10.5%$1.30B$1.14B103.153,800Trending NewsAnalyst UpgradeHSTMHealthStream4.5211 of 5 stars$29.13+2.2%$31.50+8.1%+2.0%$889.19M$292.37M44.821,140CRTXCortexymeN/A$0.85+1.3%N/A+15.7%$25.63MN/A-0.2955NTCTNetScout Systems1.2673 of 5 stars$23.56+1.1%$25.00+6.1%+8.6%$1.69B$822.68M-4.022,330Positive NewsVRNTVerint Systems4.547 of 5 stars$17.93-1.4%$30.33+69.2%-44.9%$1.08B$909.19M19.074,400Positive NewsGap DownRBBNRibbon Communications4.695 of 5 stars$3.64+0.3%$5.88+61.4%+11.7%$642.62M$835.50M-11.383,107Positive NewsGap DownSLPSimulations Plus3.7007 of 5 stars$31.33-0.6%$50.00+59.6%-35.0%$630.08M$78.56M78.33160Positive NewsOSPNOneSpan4.5082 of 5 stars$16.30+0.4%$19.50+19.6%+24.8%$623.15M$241.70M22.03790Positive NewsDividend AnnouncementAnalyst DowngradeECXECARX1.9064 of 5 stars$1.50-5.7%$3.20+113.3%+38.3%$556.10M$5.85B-3.002,000UISUnisys4.5203 of 5 stars$5.24-2.4%$6.50+24.0%+3.6%$372.39M$1.95B-1.8516,200Positive News Related Companies and Tools Related Companies Omnicell Competitors HealthStream Competitors Cortexyme Competitors NetScout Systems Competitors Verint Systems Competitors Ribbon Communications Competitors Simulations Plus Competitors OneSpan Competitors ECARX Competitors Unisys Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MDRX) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Veradigm Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Veradigm With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.